Correction: LC-MS/MS characterization of pirtobrutinib impurities and product degradation: stability studies
Abstract
Correction for ‘LC-MS/MS characterization of pirtobrutinib impurities and product degradation: stability studies’ by Modachakanahally K. Pavithra et al., RSC Adv., 2024, 14, 34868–34882, https://doi.org/10.1039/D4RA06299J.
                                            Please wait while we load your content...